KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Pacific Biosciences Of California (PACB) over the last 17 years, with Q3 2025 value amounting to -$2.7 billion.

  • Pacific Biosciences Of California's Retained Earnings fell 2341.07% to -$2.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 billion, marking a year-over-year decrease of 2341.07%. This contributed to the annual value of -$2.1 billion for FY2024, which is 1684.82% down from last year.
  • Latest data reveals that Pacific Biosciences Of California reported Retained Earnings of -$2.7 billion as of Q3 2025, which was down 2341.07% from -$2.6 billion recorded in Q2 2025.
  • Pacific Biosciences Of California's Retained Earnings' 5-year high stood at -$1.1 billion during Q1 2021, with a 5-year trough of -$2.7 billion in Q3 2025.
  • In the last 5 years, Pacific Biosciences Of California's Retained Earnings had a median value of -$1.7 billion in 2023 and averaged -$1.8 billion.
  • Its Retained Earnings has fluctuated over the past 5 years, first crashed by 332.42% in 2021, then plummeted by 3430.68% in 2025.
  • Pacific Biosciences Of California's Retained Earnings (Quarter) stood at -$1.2 billion in 2021, then dropped by 25.8% to -$1.5 billion in 2022, then dropped by 20.02% to -$1.8 billion in 2023, then decreased by 16.85% to -$2.1 billion in 2024, then fell by 23.55% to -$2.7 billion in 2025.
  • Its Retained Earnings stands at -$2.7 billion for Q3 2025, versus -$2.6 billion for Q2 2025 and -$2.6 billion for Q1 2025.